FEATURED NEWS
NEWS: ACUITAS THERAPEUTICS FOUNDERS RECEIVE GOVERNOR GENERAL’S INNOVATION AWARD (APR 2022)
The founders of Acuitas Therapeutics, Drs. Pieter Cullis, Michael Hope and Thomas Madden, have been named as Governor General’s Innovation Award recipients. Read about it here.
NEWS: ACUITAS DONATES $50,000 TO SUPPORT HUMANITARIAN EFFORTS IN UKRAINE (MAR 2022)
Acuitas has donated to the Canadian Red Cross to support that organization’s humanitarian efforts in Ukraine. Read about it here.
NEWS: PFIZER ENTERS INTO AGREEMENT WITH ACUITAS FOR USE OF LIPID NANOPARTICLE DELIVERY SYSTEM (JAN 2022)
Acuitas and Pfizer have entered into a Development and Option agreement under which Pfizer will have the option to license, on a non-exclusive basis, Acuitas’ LNP technology for up to 10 targets for vaccine or therapeutic development. Read about it here.